Akèy › Dyabèt Tip 2 › New York
Etid klinik pou Dyabèt Tip 2 nan New York
33 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan New York.
Vil nan New York
- New York City16 etid
- Brooklyn7 etid
- The Bronx6 etid
- Syracuse5 etid
- Buffalo5 etid
- Manhattan3 etid
- Cheektowaga3 etid
- Albany3 etid
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Ellipsis Research Group - Brooklyn, Brooklyn
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Albany Med Health System - Washington Avenue Extension, Albany
- Velocity Clinical Research - Binghamton, Binghamton
- RCR - Buffalo, Buffalo
- ak 7 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Rochester Clinical Research - Buffalo, Buffalo
- CHEAR Center LLC, The Bronx
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Clindove Research, Brooklyn
- Swift Clinical Research, Brooklyn
- Rasaj Research, Jackson Heights
- ak 4 plis
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
- Rochester Clinical Research, LLC, Rochester
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NYC Research INC, Long Island City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, East Northport
- AURORA-2 Clinical Site, East Syracuse
- AURORA-2 Clinical Site, New Windsor
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes
- NYU Langone Health, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06319716A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Brooklyn Clinical Research, Brooklyn
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- NYC Research INC, Long Island City
- Richmond University Medical Center, Staten Island
- Southgate Medical Group, West Seneca
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Velocity Clinical Research, Binghamton
- CHEAR Center LLC, The Bronx
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- UBMD Pediatrics, Buffalo
- NYU Langone Orthopedic Center, New York
Ap rekriteFaz 3
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Albany Medical College, Albany
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484Graded Insulin Suppression Test P&F
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 8, 2026 · NCT06592261Alpelisib Challenge Test (ACT)
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07778524A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, The Bronx
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Central New York Clinical Research CNYCR, Manlius
- Mid Hudson Med Res-New Windsor, New Windsor
- Harlem Cardiology_Madison ave, New York
- ak 3 plis
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Brooklyn
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- SUNY Upstate Medical Center, Albany
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599982APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
- Weill Cornell Medicine, New York
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 19, 2026 · NCT07773779A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- WBMD Pediatrics, Buffalo
- Cohen Children's Medical Center Division of Pediatric Endocrinology, Hyde Park
- SUNY Upstate Medical University, Syracuse
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- The Mount Sinai Hospital, New York
- SUNY Syracuse, Syracuse
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07521475Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
- State University of New York at Buffalo, South Campus, Buffalo
Ap rekrite
Laj 18 a 60 · Tout sèks · Mizajou Jun 11, 2026 · NCT07641361Milk for Diabetes Prevention
- HCHS/SOL Bronx Field Center, The Bronx
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou May 26, 2026 · NCT06513026ED Diabetes Screening and Outpatient Care - Aim 3
- NYU Langone Health, New York
Ap rekrite
Laj 20 a 70 · Tout sèks · Mizajou May 19, 2026 · NCT05899023DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- NYU Langone Health- Brooklyn, Brooklyn
- NYU Langone Health- Long Island, Garden City
- NYU Langone Health- Manhattan, New York
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 8 a 15 · Tout sèks · Mizajou May 7, 2026 · NCT06525259Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
- NYU Langone Health, New York
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Mar 9, 2026 · NCT06319703High Fructose Diet, the Gut Microbiome, and Metabolic Health
- Mount Sinai Morningside, New York
Ap rekriteVolontè an sante akeyi
Laj 25 a 45 · Tout sèks · Mizajou Dec 17, 2025 · NCT06329544Effects of HIIT vs. TRE on Type 2 Diabetes Risk
- Syracuse University, Syracuse
Ap rekriteVolontè an sante akeyi
Laj 14 a 30 · Tout sèks · Mizajou Oct 10, 2025 · NCT07215533Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- Clindove Research LLC, Brooklyn
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2025 · NCT07106879NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Ap rekriteEtid obsèvasyon
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106RESET System Pivotal Trial (Rev F)
- Weill Cornell Medicine, New York
Ap rekrite
Laj 22 a 65 · Tout sèks · Mizajou Jul 18, 2024 · NCT04101669Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
- Brooklyn Clinical Research, Brooklyn
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2024 · NCT06412536Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.